Covestor
VIR icon

Covestor’s Vir Biotechnology VIR Stock Holding History

Covestor’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Sell
23
-16
-41% -$160 ﹤0.01% 2873
2026
Q2 		$0 Buy
39
+28
+255% +$266 ﹤0.01% 2874
2026
Q1 		$0 Hold
11
– – ﹤0.01% 2812
2025
Q4 		$0 Hold
11
– – ﹤0.01% 2777
2025
Q3 		$0 Hold
11
– – ﹤0.01% 2818
2025
Q2 		$0 Sell
11
-1
-8% -$5 ﹤0.01% 2798
2025
Q1 		$0 Sell
12
-15
-56% -$133 ﹤0.01% 2768
2024
Q4 		$0 Buy
27
+16
+145% +$126 ﹤0.01% 2784
2024
Q3 		$0 Sell
11
-1
-8% -$9 ﹤0.01% 2815
2024
Q2 		$0 Hold
12
– – ﹤0.01% 2801
2024
Q1 		$0 Sell
12
-1
-8% -$10 ﹤0.01% 2788
2023
Q4 		$0 Sell
13
-4,524
-100% -$41.3K ﹤0.01% 2764
2023
Q3 		$43K Sell
4,537
-4,668
-51% -$66.6K 0.03% 834
2023
Q2 		$226K Buy
9,205
+9,196
+102,178% +$231K 0.17% 86
2023
Q1 		$0 Hold
9
– – ﹤0.01% 2631
2022
Q4 		$0 Hold
9
– – ﹤0.01% 2650
2022
Q3 		$0 Sell
9
-190
-95% -$4.83K ﹤0.01% 2662
2022
Q2 		$5K Sell
199
-83
-29% -$1.94K ﹤0.01% 1434
2022
Q1 		$7K Buy
282
+125
+80% +$3.71K ﹤0.01% 1430
2021
Q4 		$7K Buy
+157
New +$6.15K 0.01% 1182

Other funds holding VIR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Covestor's VIR Position: Q3 2026 in Review

Covestor reduced its Vir Biotechnology (VIR) stake by 41% in Q3 2026, selling an estimated $160 and leaving 23 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

Covestor first reported a position in VIR in Q4 2021 and has held it in 20 quarters since. The position peaked at $226K in Q2 2023. 202 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Covestor held 23 shares of Vir Biotechnology worth $0 as of Q3 2026.
  • Covestor sold 16 Vir Biotechnology shares in Q3 2026, an estimated $160.
  • Vir Biotechnology made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2873 holding.
  • Covestor first reported a position in Vir Biotechnology in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Vir Biotechnology position peaked at $226K in Q2 2023.
  • 202 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.